March 2013





This page gives you a listing of everything that has happened on the site this month. There are no active links.


    08.01.09, Omacetaxine mepesuccinate (Synribo®)
    New Policy
    Posted: 3/28/2013


    08.01.05, Carfilzomib (Kyprolis™)
    New Policy
    Posted: 3/28/2013


    08.00.78i, Self-Injectable Drugs
    Policy Update
    Posted: 3/27/2013


    07.08.01e, Non-Surgical Spinal Decompression Therapy
    Policy Update
    Posted: 3/27/2013


    00.01.25q, PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services
    Policy Update
    Posted: 3/22/2013


    05.00.08c, Continuous Passive Motion (CPM) Devices in the Home Setting
    Reissue
    Posted: 3/21/2013


    11.14.13e, Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions
    Reissue
    Posted: 3/20/2013


    08.00.54d, Radioimmunotherapy with Tositumomab and Iodine I-131 Tositumomab (the Bexxar® Therapeutic Regimen)
    Reissue
    Posted: 3/20/2013


    08.00.08e, Radioimmunotherapy with Ibritumomab Tiuxetan (Zevalin®)
    Reissue
    Posted: 3/20/2013


    05.00.32d, Speech- and Non-Speech-Generating Devices
    Reissue
    Posted: 3/20/2013


    00.03.02n, Diagnostic Radiology Services Included in Capitation
    Policy Update
    Posted: 3/18/2013


    11.14.25a, Total Ankle Arthroplasty/Replacement
    Notification
    Posted: 3/13/2013


    12.00.01e, Acupuncture
    Policy Update
    Posted: 3/13/2013


    08.00.80c, Temozolomide (Temodar®) for Injection
    Policy Update
    Posted: 3/13/2013


    05.00.12d, Manual Wheelchairs
    Policy Update
    Posted: 3/13/2013


    05.00.71b, Standing Frames
    Policy Update
    Posted: 3/13/2013


    07.00.09c, Topical Oxygenation
    Reissue
    Posted: 3/8/2013


    06.02.17c, Serodiagnosis of Inflammatory Bowel Disease (IBD) and the Prometheus® IBD sgi Diagnostic™ Test
    Policy Update
    Posted: 3/8/2013


    08.00.93a, C1 Esterase Inhibitors (Human): Cinryze® and Berinert®
    Reissue
    Posted: 3/8/2013


    10.04.01j, Pulmonary Rehabilitation
    Reissue
    Posted: 3/8/2013


    11.04.01b, Islet Cell Transplantation
    Reissue
    Posted: 3/8/2013


    09.00.42b, Computer Aided Detection (CAD) System for use with Chest Radiographs
    Reissue
    Posted: 3/8/2013


    09.00.40b, Screening for Vertebral Fracture with Dual-Energy X-ray Absorptiometry (DEXA/DXA)
    Reissue
    Posted: 3/8/2013


    09.00.24b, Full-Body Computerized Tomography (CT) Scan Screening
    Reissue
    Posted: 3/8/2013


    06.02.04c, Fetal Fibronectin Enzyme (fFN) Immunoassay
    Reissue
    Posted: 3/8/2013


    05.00.35b, Foot Orthotics and Other Podiatric Appliances
    Reissue
    Posted: 3/8/2013


    09.00.02d, Electron Beam Computed Tomography (EBCT) for Screening Evaluations
    Reissue
    Posted: 3/8/2013


    Voluntary Product Recall of the Drug OMONTYS® (peginesatide) Injection Effective February 23, 2013
    News Article
    Posted: 3/7/2013


    11.14.26, Surgical Treatments of Athletic Pubalgia
    New Policy
    Posted: 3/5/2013


    09.00.53, Magnetic Resonance Imaging (MRI) for Monitoring the Integrity of Silicone-Gel-Filled Breast Implants in Asymptomatic Individuals
    Notification
    Posted: 3/1/2013




    Issued on - 4/1/2013